MEDICALI
ActiveSummary
MEDICALI has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €509k and a net result of €74k. Equity is growing by ~11.3% per year across the filed fiscal years. Its solvency ranks better than 94% of 19908 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
96
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability86▲+5
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €45k at 30 days acceptable
Liquidity ample (current ratio 22.23 against 8.94 in 2023; short-term debt: 3.4% and cash: 55.1% of total assets), and 3.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
96.5%
Return on assets
14%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 16-07-2025, 15 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
15 d early
2023
40 d early
2022
66 d late
2021
19 d early
2020
131 d late
2019
122 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€509k▲ 17.0%
2023 · €435k
2018: €277k
2019: €272k
2020: €317k
2021: €351k
2022: €388k
2023: €435k
2018 → 2024
Total assets
€527k▲ 12.9%
2023 · €467k
2018: €360k
2019: €394k
2020: €383k
2021: €400k
2022: €416k
2023: €467k
2018 → 2024
Net result
€74k▲ 56.2%
2023 · €47k
2018: €26k
2019: €34k
2020: €45k
2021: €34k
2022: €37k
2023: €47k
2018 → 2024
Working capital
€383k▲ 50.3%
2023 · €255k
2018: €-16k
2019: €-16k
2020: €59k
2021: €129k
2022: €176k
2023: €255k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€317k-€351k▲ 10.9%€388k▲ 10.4%€435k▲ 12.2%€509k▲ 17.0%
Operating result€64k-€50k▼ 23.0%€51k▲ 3.2%€72k▲ 40.4%€109k▲ 52.0%
Net result€45k-€34k▼ 23.4%€37k▲ 6.2%€47k▲ 29.5%€74k▲ 56.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2021 the operating result has climbed three years in a row; 2024 is 52% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €527k
Fixed assets
€126k ▼ 30.1%
Current assets
€401k ▲ 39.8%
Equity and liabilities €527k
Equity
€509k ▲ 17.0%
Debt
€18k ▼ 43.5%
Debt's share of the balance-sheet total falls from 6.9% to 3.5%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€137k▲
2023 · €104k
Cash flow
€101k▲
2023 · €80k
Current ratio
22.23▲
2023 · 8.94
Debt to equity
0.04▼
2023 · 0.07
ROE
14.6%▲
2023 · 10.9%
ROA
14.0%▲
2023 · 10.2%
Interest coverage
722.60▲
2023 · 193.21
Debt ≤ 1 year
€18k▼
2023 · €32k
Income taxes
€36k▲
2023 · €24k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 43 lines
Balance sheet
Code20232024
Assets
Total assets20/58€467k€527k▲
Fixed assets21/28€180k€126k▼
Tangible fixed assets22/27€180k€126k▼
Land and buildings22€149k€125k▼
Furniture and vehicles24€31k€587▼
Financial fixed assets28€50€50=
Current assets29/58€287k€401k▲
Amounts receivable within one year40/41€6k€107k▲
Trade receivables40€420€2k▲
Other amounts receivable41€6k€106k▲
Cash at bank and in hand54/58€277k€290k▲
Deferred charges and accrued income490/1€4k€4k▼
Equity and liabilities
Total equity and liabilities10/49€467k€527k▲
Equity10/15€435k€509k▲
Contributions10/11€20k€20k=
Reserves13€415k€489k▲
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€413k€487k▲
Amounts payable17/49€32k€18k▼
Amounts payable within one year42/48€32k€18k▼
Trade debts44€305€3k▲
Suppliers440/4€305€3k▲
Taxes, remuneration and social security45€5k€15k▲
Taxes450/3€4k€11k▲
Remuneration and social security454/9€530€4k▲
Other amounts payable47/48€27k-
Accrued charges and deferred income492/3€173€183▲
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€32k€27k▼
Other operating charges640/8€1k€3k▲
Gross operating margin9900€105k€140k▲
Operating profit (loss)9901€72k€109k▲
Financial income75/76B€512€1k▲
Recurring financial income75€512€1k▲
Financial charges65/66B€540€189▼
Recurring financial charges65€540€189▼
Profit (loss) for the period before taxes9903€72k€110k▲
Income taxes67/77€24k€36k▲
Profit (loss) for the period9904€47k€74k▲
Profit (loss) for the period to be appropriated9905€47k€74k▲
Appropriation of the result
Profit (loss) to be appropriated9906€47k€74k▲
Transfer to equity691/2€47k€74k▲
To other reserves6921€47k€74k▲
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
16-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2018net €74k ▲56.2%
Operating result €109k, net result €74k, both a record.
31-12
Financial
Liquidity doublescurrent ratio 22.23
Current ratio from 8.94 to 22.23; short-term debt falls from €32k to €18k.
31-12
Financial
Equity above €500kEq €509k ▲17%
7 profitable years in a row build equity to €509k.
21-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
05-10
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 66 days late
2022
12-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
09-12
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 131 days late
2020
31-12
Financial
Liquidity doublescurrent ratio 1.91
Current ratio from 0.86 to 1.91; short-term debt falls from €112k to €64k.
30-11
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 122 days late
2019
19-09
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 50 days late
2018
03-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 3 days late
2017
29-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 29 days late
2016
05-08
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 5 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Honnelles · 2 establishment units since 2003
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Chemin du Caillou-qui-Bique(A) 77387 HonnellesGround area
3,485 m²
Building footprint
315 m²
Volume, LiDAR
904 m³
2 parcels, Wallonia · tallest building 6.7 m, ±2 floors. Linked by address, not a title deed.
2 establishment units
MEDICALI
since 20032.257.368.954
MEDICALI
since 20162.257.369.350
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 53001A0459/00Z000 | Wallonia | 3,102 m² | 1 · 169 m² | 6.7 m · 2 fl. |
| 53001A0594/00C000 | Wallonia | 383 m² | 1 · 146 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Plate-Forme Liégeoise de Concertation en Santé Mentale
BE 0448.470.293
Liège · Eq €517k
Dokter I. Van Looveren
BE 0451.121.462
Antwerpen · Eq €500k
MERA CURA
BE 0420.151.540
Buggenhout · Eq €498k
Beratungs- und Therapiezentrum VoG
BE 0416.454.850
Eupen · Eq €524k
ENJOY TODAY
BE 0426.728.338
Oudenaarde · Eq €527k
Of 10,451 companies in sector 86995 we hold annual accounts for 886. 504 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded04-07-2003
Fiscal year end31-12
Activities, NACEBEL 2025
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 22 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:m.carton@outlook.com